Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Receptor Life Sciences
AddedFeb 17, 2024
UpdatedJun 18, 2026
Receptor Life Sciences

Receptor Life Sciences

Series A

Receptor Life Sciences: Biotech firm specializing in therapies for nervous system disorders and drug-delivery technologies.

HQ
Seattle, WA, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Receptor Life Sciences, founded with a mission to address unmet medical needs, specializes in developing therapies for nervous system disorders and innovative drug-delivery technologies. The company focuses on creating oral cannabinoid products and other advanced therapeutic solutions aimed at improving patient outcomes in neurology and related fields. Their market focus includes providing effective treatments for rare diseases, pain management, and primary care.

The team at Receptor Life Sciences comprises seasoned leaders with extensive backgrounds in research, clinical development, and commercialization. Notable figures include healthcare executives with decades of experience in neurology and rare diseases. The company has achieved significant milestones in pre-clinical and clinical trials, positioning itself as a key player in the biotechnology sector. Through its innovative approaches, Receptor Life Sciences has made a substantial impact on the treatment landscape for nervous system disorders.

Receptor Life Sciences - Similar Companies

Receptor BioLogix logo

Receptor BioLogix

Reactive Biosciences logo

Reactive Biosciences

reactivebio.com

Reservoir Neuroscience logo

Reservoir Neuroscience

reservoirneuro.com

Syntis Bio logo

Syntis Bio

syntis.bio

Neurocarrus logo

Neurocarrus

neurocarrus.com

ReNetX Bio logo

ReNetX Bio

renetx.com

Judo Bio logo

Judo Bio

Rediscovery Life Sciences logo

Rediscovery Life Sciences

rediscoveryls.com

RLS Therapeutics logo

RLS Therapeutics

Cerebral Therapeutics logo

Cerebral Therapeutics

Orphan Star Therapeutics logo

Orphan Star Therapeutics

Neurolixis logo

Neurolixis

neurolixis.com

Kurve Therapeutics logo

Kurve Therapeutics

kurvetx.com

Brii Biosciences logo

Brii Biosciences

briibio.com

Kezar Life Sciences logo

Kezar Life Sciences

Receptor Life Sciences - Quick Facts

Who are Receptor Life Sciences' competitors?

Companies similar to Receptor Life Sciences include Receptor BioLogix, Reactive Biosciences, Reservoir Neuroscience and Syntis Bio.

When was Receptor Life Sciences founded?

Receptor Life Sciences was founded in 2015.

Where is Receptor Life Sciences' headquarters located?

Receptor Life Sciences' headquarters is located in Seattle, WA, US.

When was Receptor Life Sciences' last funding round?

Receptor Life Sciences' most recent funding round was for $9.7M (USD) in April 2022.

How much has Receptor Life Sciences raised to-date?

As of Apr 7, 2022, Receptor Life Sciences has raised a total of $46.3M (USD).

How many employees does Receptor Life Sciences have?

Receptor Life Sciences has 12 employees as of Feb 5, 2024.

Receptor Life Sciences - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Drug Delivery
  • Therapies
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified